Is Evogene Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: EVGN) stock is to Strong Buy EVGN stock.
Out of 1 analyst, 1 (100%) are recommending EVGN as a Strong Buy, 0 (0%) are recommending EVGN as a Buy, 0 (0%) are recommending EVGN as a Hold, 0 (0%) are recommending EVGN as a Sell, and 0 (0%) are recommending EVGN as a Strong Sell.
What is EVGN's revenue growth forecast for 2024-2024?
(NASDAQ: EVGN) Evogene's forecast annual revenue growth rate of 519.33% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 230.34%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.87%.
Evogene's revenue in 2024 is $5,640,000.
In 2024, EVGN is forecast to generate $1,766,930,138 in revenue, with the lowest revenue forecast at $1,766,930,138 and the highest revenue forecast at $1,766,930,138.
What is EVGN's forecast return on assets (ROA) for 2024-2025?
(NASDAQ: EVGN) forecast ROA is -32.67%, which is lower than the forecast US Biotechnology industry average of 9.48%.
What is EVGN's Price Target?
According to 1 Wall Street analyst that have issued a 1 year EVGN price target, the average EVGN price target is $1.85, with the highest EVGN stock price forecast at $1.85 and the lowest EVGN stock price forecast at $1.85.
The Wall Street analyst predicted that Evogene's share price could reach $1.85 by Oct 2, 2024. The average Evogene stock price prediction forecasts a potential upside of 151.7% from the current EVGN share price of $0.74.
What is EVGN's forecast return on equity (ROE) for 2024-2025?
(NASDAQ: EVGN) forecast ROE is -138.5%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.